Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
18.75
+0.61 (3.36%)
At close: Nov 13, 2026, 4:00 PM EST
18.80
+0.05 (0.27%)
Pre-market: Nov 16, 2026, 7:00 AM EST
Acadia Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $28 → $24 | Hold | Maintains | $28 → $24 | +28.00% | Nov 13, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $31 | Buy | Maintains | $31 | +65.33% | Nov 11, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $34 | Buy | Maintains | $34 | +81.33% | Nov 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $36 → $38 | Buy | Reiterates | $36 → $38 | +102.67% | Nov 6, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Maintains $27 | Buy | Maintains | $27 | +44.00% | Nov 5, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $37 | Buy | Maintains | $37 | +97.33% | Nov 5, 2026 |
| Oppenheimer | Oppenheimer | Hold Maintains $23 | Hold | Maintains | $23 | +22.67% | Nov 5, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $36 → $38 | Buy | Reiterates | $36 → $38 | +102.67% | Nov 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.